← Back to Search

Ablation Therapy

Treatment for Prostate Cancer (CARE Trial)

N/A
Recruiting
Research Sponsored by Profound Medical Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up lifelong up to 99 years
Awards & highlights

Summary

This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.

Eligible Conditions
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Enlarged Prostate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~lifelong up to 99 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and lifelong up to 99 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Freedom from treatment failure
Rate of complications
Secondary study objectives
Biopsy Data
Complications Data
Financial Data- Total Costs
+15 more

Find a Location

Who is running the clinical trial?

Profound Medical Inc.Lead Sponsor
3 Previous Clinical Trials
381 Total Patients Enrolled
3 Trials studying Prostate Cancer
381 Patients Enrolled for Prostate Cancer
~407 spots leftby Oct 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top